https://www.marketscreener.com/quote/stock/CELLTRION-INC-40742914/news/Celltrion-s-COVID-19-Treatment-Candidate-Receives-Korean-MFDS-Conditional-Marketing-Authorisation-33533721/?utm_source=telegram&utm_medium=social&utm_campaign=share